MedTrace Logo

The Turkish Version of the Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS)

NCT05210959 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2022-02-15

No results posted yet for this study

Summary

The Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS) is an instrument that assesses the quality and quantity of motor development opportunities available in the home for infants aged 3 to 18 months. Since its initial publication, the AHEMD-IS has grown in popularity as a clinical tool and research criterion. Furthermore, the AHEMD-IS supports the claim that environmental factors can have a positive impact on future motor skills and later cognitive behaviors of infants. Also it is stated that environmental factors are associated with infant motor development and motor abilities. As of writing, it has been translated into eight languages from the original English version and has been reported as valid and reliable in countries such as China, Spain, Lebanon, and Persia. The aim of this study was to produce the Turkish version of the AHEMD-IS and to reveal the validity and reliability of this version.

Conditions

  • Premature
  • Infant Development
  • Environmental Exposure

Interventions

OTHER

The Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS)

The Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS) is an instrument that assesses the quality and quantity of motor development opportunities available in the home for infants aged 3 to 18 months. In this study, the Turkish version of the AHEMD-IS were constructed. Also, the validity and reliability of this version were examined.

Sponsors & Collaborators

  • Gazi University

    lead OTHER

Principal Investigators

  • Bulent Elbasan, Prof. · Gazi University

Eligibility

Min Age
3 Months
Max Age
18 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-12-30
Completion
2022-01-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05210959 on ClinicalTrials.gov